Skip to content

Shares (Basic) at other companies

Amgen logo
AmgenAMGN
540M+0.4%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
104M-2.5%
Gilead Sciences logo
Gilead SciencesGILD
1.2B-0.3%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
66.4M+52.1%
Iovance Biotherapeutics, Inc. logo
Iovance Biotherapeutics, Inc.IOVA
418.5M+29.6%
Nuvation Bio logo
Nuvation BioNUVB
347.3M+2.6%

Other financials

Income statement

See full
Revenue-$29.0K-101%
Gross profit$1.2M-60.2%
Operating income-$132.3M+5.2%
Net income-$125.7M-3.9%
EPS (diluted)-$0.85+3.4%

Balance sheet

See full
Cash & equivalents$283.0M-23.1%
Total debt$95.6M-0.5%
Total equity$812.8M-22.1%
Total assets$1.0B-21.6%

Cash flow

See full
Operating cash flow-$132.4M-69.5%
CapEx$390.0K-76.1%
Free cash flow-$132.8M-66.5%

Valuation

See full
Market cap$1.71B+61.1%
Enterprise value$1.53B+102%
P/S26.2×-24.8×

Profitability

See full
Gross margin96.1%-2.7pp
Operating margin-720.8%-313pp
Net margin-676%-291pp
FCF margin-686.5%-273pp

Returns & leverage

See full
Return on equity-47.7%+3.6pp
Debt / equity0.1×0.0×
Current ratio7.1×+0.3×

Where this comes from

Reported directly by Vir Biotechnology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vir Biotechnology, Inc.'s shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vir Biotechnology, Inc.'s shares (basic)?
Vir Biotechnology, Inc. (VIR) reported shares (basic) of 147.4M in Q1 2026.
How has Vir Biotechnology, Inc.'s shares (basic) changed year-over-year?
Vir Biotechnology, Inc.'s shares (basic) increased by 7.2% year-over-year, from 137.5M to 147.4M.
What is the long-term trend for Vir Biotechnology, Inc.'s shares (basic)?
Over 4 years (2021 to 2025), Vir Biotechnology, Inc.'s shares (basic) has grown at a 1.6% compound annual growth rate (CAGR), from 518.4M to 553.4M.
What does shares (basic) mean?
The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.